Artivion director receives 7,576-share stock grant
Bullock James reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Bullock James reported acquisition or exercise transactions in this Form 4 filing.
ARTIVION, INC. director James Bullock reported receiving a grant of 7,576 shares of Common Stock as equity compensation. The award carried a price of $0.00 per share and increased his directly held stake to 76,223 shares. According to the disclosure, this restricted stock award vests on May 18, 2027 under the company’s Equity and Cash Incentive Plan, indicating it is a time-based compensation grant rather than an open-market purchase.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 7,576 | $0.00 | $0.00 |
Footnotes (1)
- F1. RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.
Key Figures
Key Terms
Restricted Stock Award financial
Equity and Cash Incentive Plan financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did ARTIVION (AORT) director James Bullock report?
Was the ARTIVION (AORT) insider transaction a market purchase or a stock grant?
What does Form 4 transaction code A mean for ARTIVION (AORT)?
AI-generated analysis. How Rhea-AI works. Not financial advice.